{
    "nctId": "NCT02802553",
    "briefTitle": "Evaluation of an Integrated Imaging System For In Vivo Detection of Fluorescently Labeled Lesions",
    "officialTitle": "Evaluation of an Integrated Imaging System (Smart Goggles) For In Vivo Detection of Fluorescently Labeled Lymph Nodes for Breast Cancer: A Pilot Study To Visualize Sentinel Lymph Nodes After Periareolar Injection of Indocyanine Green",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "Invasive Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "DIAGNOSTIC",
    "enrollmentCount": 2,
    "primaryOutcomeMeasure": "Binary response of the number of participants in which the Smart Goggles identifies the same Sentinel Lymph Nodes (SLN) within each participant as those identified by the gamma probe and blue dyes gold standard.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Subjects with at least 1 lesion of tumor of the breast\n* Subjects must have the ability to understand and the willingness to sign a written informed consent document.\n\nExclusion Criteria:\n\n* Subjects who have been treated with radiation therapy on the chest.\n* Has had previous sentinel lymph node biopsy\n* Has a known hypersensitivity to ICG, methylene blue and 99mTc-colloid.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}